Operating cash flow increased 81.6%
Operating cash flow changed +81.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +81.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +58.9% from the comparable as-filed period.
Revenue changed +40.6% from the comparable as-filed period.
Operating margin changed +773250 basis points from the comparable as-filed period.
Net income changed +47.7% from the comparable as-filed period.
Shares outstanding changed -89.5% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes. This reverses 7 consecutive comparable moves in the opposite direction.
Research & development changed -83.9% from the comparable as-filed period.
Current assets changed -46.9% from the comparable as-filed period. The change ranks at the 40th percentile of 5 prior comparable changes.
Current liabilities changed -73.6% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Stockholders' equity changed -43.3% from the comparable as-filed period.
Total assets changed -47.2% from the comparable as-filed period. The change ranks at the 40th percentile of 5 prior comparable changes.
Working capital changed -42.9% from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
SBC / revenue changed -31718 basis points from the comparable as-filed period.
Current ratio changed +100.8% from the comparable as-filed period. The change ranks at the 40th percentile of 5 prior comparable changes.
Working capital / assets changed +703 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Stock-based compensation changed -17.6% from the comparable as-filed period.
Operating cash-flow margin changed +1360291 basis points from the comparable as-filed period.
R&D / revenue changed -626154 basis points from the comparable as-filed period.
Cash & equivalents changed +4.0% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Net debt changed -4.0% from the comparable as-filed period.
Debt / assets changed +0 basis points from the comparable as-filed period.
Debt / equity changed +0 basis points from the comparable as-filed period.
Debt / revenue changed +0 basis points from the comparable as-filed period.
Gross debt changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Reported total debt changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.